GEMMUS PHARMA
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
GEMMUS PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.gemmuspharma.com
Total Employee:
11+
Status:
Active
Contact:
4159781908
Email Addresses:
[email protected]
Total Funding:
5.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail Google Maps ReCAPTCHA GoDaddy DNS Google Google Maps API
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
NLT SPINE
NLT SPINE develops minimally invasive spinal surgery products for the treatment of degenerative spinal conditions.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Wilmington Investor Network
Wilmington Investor Network investment in Series B - Gemmus Pharma
The Angels' Forum
The Angels' Forum investment in Series B - Gemmus Pharma
Life Science Angels
Life Science Angels investment in Series B - Gemmus Pharma
BlueTree Allied Angels
BlueTree Allied Angels investment in Series B - Gemmus Pharma
Tech Coast Angels
Tech Coast Angels investment in Series B - Gemmus Pharma
The Angels' Forum
The Angels' Forum investment in Series A - Gemmus Pharma
Wilmington Investor Network
Wilmington Investor Network investment in Series A - Gemmus Pharma
BlueTree Allied Angels
BlueTree Allied Angels investment in Series A - Gemmus Pharma
Tech Coast Angels
Tech Coast Angels investment in Series A - Gemmus Pharma
Life Science Angels
Life Science Angels investment in Series A - Gemmus Pharma
Official Site Inspections
http://www.gemmuspharma.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Gemmus Pharma"
Gemmus Pharma Inc - Company Profile and News - Bloomberg …
Company profile page for Gemmus Pharma Inc including stock price, company news, executives, board members, and contact informationSee details»
Gemmus Pharma - PitchBook
Gemmus Pharma General Information Description. Developer of therapeutics designed to treat influenza and other infectious diseases. The company's therapeutics include GP1681, a non …See details»
Gemmus Pharma Inc. | San Francisco, CA, USA Startup
Aug 1, 2007 Gemmus Pharma Inc. is a privately held company incorporated in August 2007 to develop host-targeted treatments for moderate to life-threatening influenza infections. Gemmus' lead candidate was identified at a major …See details»
Gemmus Pharma, Inc. - Drug pipelines, Patents, Clinical trials
Explore Gemmus Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:GP-1002, GP-1681.See details»
Gemmus Pharma - Overview, News & Similar companies - ZoomInfo
Gemmus Pharma. Drug Stores & Pharmacies · California, United States · <25 Employees. View Company Info for Free. About. Headquarters 409 Illinois St Ste 4004, San Francisco, Califo...See details»
Gemmus Pharma - Products, Competitors, Financials, Employees ...
Gemmus Pharma Closes $3.3M Series B Funding to Develop Superior Flu Drug. May 13, 2014. uTest Closes Million Series E Round Led by Goldman Sachs / Ahead of Rebrand to …See details»
Gemmus Pharma - Crunchbase
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.See details»
Gemmus Pharma - Contacts, Employees, Board Members
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.See details»
Gemmus Pharma Inc. - BioCentury Company Profiles - BCIQ
May 19, 2014 Gemmus Pharma Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Gemmus Pharma - VentureRadar
Gemmus is a privately held biotechnology company focused on the development of innovative pharmaceutical products for the treatment of infectious... ... Find out more ...See details»
Gemmus Pharma CEO, Founder, Key Executive Team, Board of …
Explore {Gemmus Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Gemmus Pharma Stock Price, Funding, Valuation, Revenue
May 13, 2014 See Gemmus Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on Gemmus Pharma's post-money valuation and revenue.See details»
Daryl Faulds, Gemmus Pharma Inc: Profile and Biography
Daryl Faulds is Chief Executive Officer at Gemmus Pharma Inc. See Daryl Faulds's compensation, career history, education, & memberships.See details»
Gemmus Pharma Closes on Series A Funding to Develop Superior …
Jun 28, 2012 SAN FRANCISCO--(BUSINESS WIRE)--Gemmus Pharma Inc. announced today that it has closed on a Series A funding. Gemmus is a privately held biotechnology company …See details»
Gemmus Pharma - Funding, Financials, Valuation & Investors
Gemmus Pharma is funded by 5 investors. Wilmington Investor Network and The Angels' Forum are the most recent investors. Gemmus Pharma has a post-money valuation in the range of …See details»
BlueTree Venture Fund Invests in Gemmus Pharma
BlueTree Venture Fund, a Pittsburgh-based venture capital firm recently invested in Gemmus Pharma, a San Francisco-based company focused on the innovative development of …See details»
Gemmus Pharma Adds Life Science Industry Experts to ... - Fierce …
Aug 1, 2012 Gemmus Pharma Adds Life Science Industry Experts to Board of Directors Daryl Faulds, 415-978-2151orJennifer Larson, 415-725-2017See details»
Gemmus Pharma Announces FDA Acceptance of IND ... - Business …
May 11, 2015 Gemmus Pharma William Guilford, 415-978-2151 [email protected] or For Gemmus Pharma Jennifer Larson, 415-725-2017 …See details»
Research programme: viral infection therapeutics - Gemmus Pharma
Jul 16, 2016 Gemmus is developing therapeutics that decrease the severity of symptoms in influenza and other viral infections by modulating the release of proinflammatorySee details»